Zoster iridocyclitis
ICD-10 B02.32 is a billable code used to indicate a diagnosis of zoster iridocyclitis.
Zoster iridocyclitis is an inflammatory condition of the iris and ciliary body that occurs as a complication of varicella-zoster virus (VZV) reactivation, commonly known as shingles. This condition typically presents with symptoms such as eye pain, redness, photophobia, and blurred vision. The inflammation is a result of the immune response to the viral particles that affect the ocular structures. Patients may have a history of herpes zoster, which is characterized by a painful rash that follows a dermatomal distribution. The risk of developing zoster iridocyclitis increases with age and in immunocompromised individuals. Diagnosis is primarily clinical, supported by patient history and ocular examination. Treatment often involves antiviral medications, corticosteroids to reduce inflammation, and symptomatic relief. Early recognition and management are crucial to prevent complications such as glaucoma or permanent vision loss.
Detailed ocular examination findings, including visual acuity and intraocular pressure.
Patients presenting with eye pain and a history of shingles.
Documentation must clearly indicate the relationship between herpes zoster and ocular symptoms.
History of varicella infection, vaccination status, and any immunocompromising conditions.
Patients with recurrent herpes zoster infections and associated complications.
Need to document the patient's immune status and any prior antiviral treatments.
Used for initial evaluation of a patient presenting with zoster iridocyclitis.
Complete eye examination notes, including visual acuity and intraocular pressure.
Ophthalmologists should ensure thorough documentation of ocular findings.
Common symptoms include eye pain, redness, photophobia, and blurred vision, often accompanied by a history of shingles.
Treatment typically involves antiviral medications, corticosteroids to reduce inflammation, and symptomatic relief measures.
